Bansal Wire Lists At 39% Premium, Emcure Pharma Gains 31% At Debut | Markets News
New Delhi: Two of the most anticipated IPOs Bansal Wire and Emcure Pharma saw good gains in their stock market debut on Monday. While Bain-Capital backed Emcure Pharma saw a gain of 31.45 percent, Bansal Wire registered 39% premium at listing Both Bansal Wire and Emcure Pharmaceuticals IPO closed for public subscription on July 5. […]